Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.53
-0.28 (-4.82%)
Jul 31, 2025, 12:38 PM - Market open

The Duckhorn Portfolio Stock Forecast

BOLT's stock price has decreased by -61.62% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts that cover The Duckhorn Portfolio stock have a consensus rating of "Buy" and an average price target of $50, which forecasts a 804.16% increase in the stock price over the next year. The lowest target is $20 and the highest is $80.

Price Target: $50.00 (+804.16%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$20$50$80$80
Change+261.66%+804.16%+1346.7%+1346.7%
* Price targets were last updated on May 20, 2025.

Analyst Ratings

The average analyst rating for The Duckhorn Portfolio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy000111
Buy000000
Hold555222
Sell000000
Strong Sell000000
Total555333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Lake Street
Lake Street
Strong Buy
Initiates
$80
Strong BuyInitiates$80+1,346.65%May 20, 2025
Stifel
Stifel
Hold
Maintains
$25$20
HoldMaintains$25$20+261.66%May 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
HoldReiteratesn/an/aMar 25, 2025
Stifel
Stifel
Hold
Maintains
$30$25
HoldMaintains$30$25+352.08%Mar 25, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
HoldReiteratesn/an/aNov 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
4.40M
from 7.69M
Decreased by -42.78%
Revenue Next Year
5.46M
from 4.40M
Increased by 24.14%
EPS This Year
-24.00
from -33.06
EPS Next Year
-19.04
from -24.00
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
231.00K1.26M5.73M7.88M7.69M4.40M5.46M18.81M
Revenue Growth
7.44%445.46%354.68%37.48%-2.36%-42.78%24.14%244.36%
EPS
-577.72-59.40-47.16-36.60-33.06-24.00-19.04-6.73
EPS Growth
--------
Forward PE
--------
No. Analysts
-----665
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High5.3M15.9M38.4M
Avg4.4M5.5M18.8M
Low2.9Mn/a294,000

Revenue Growth

Revenue Growth20252026202720282029
High
-31.2%
261.9%
603.2%
Avg
-42.8%
24.1%
244.4%
Low
-61.8%
-
-94.6%

EPS Forecast

EPS20252026202720282029
High-21.42-13.65-6.72
Avg-24.00-19.04-6.73
Low-25.09-27.83-6.66

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.